ARCHIVES

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Cancer Act Renewals Marked By Disputes Over NCI Authorities

October 5, 1990

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011

IOM Finds Asbestos Causes Cancer of the Larynx.

June 16, 2006

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010

Cancergrams Cost $840 Year For All

December 2, 1977